<DOC>
	<DOCNO>NCT00327626</DOCNO>
	<brief_summary>The aim study evaluate safety , tolerability , pharmacokinetics two ISIS 113715 subcutaneous dos ( 15 mg 30 mg/day ) combination oral antidiabetic agent ( OAD ) versus OAD + placebo patient inadequately control type 2 diabetes , despite ongoing maximal treatment OAD .</brief_summary>
	<brief_title>Safety , Tolerability , Activity ISIS 113715 People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Male female ( postmenopausal and/or surgically sterile ) Aged 18 70 year Diagnosed type 2 diabetes mellitus eight year le duration Being treat OAD stable maximum dos [ define least 10 mg/day glibenclamide ( prefer ) , 20 mg/day glipizide , without least 1,500 mg/day metformin ] least three month prior screen Having fast plasma glucose level 150270 mg/dL HbA1c level 7.511.0 % Greater 3 severe hypoglycemic episode within six month screen Pregnant , breastfeeding , intend become pregnant Clinical sign symptom liver disease , acute , chronic hepatitis , ALT great upper limit normal Positive hepatitis B surface antigen , hepatitis C antibody , HIV test Patients history renal transplantation renal dialysis microalbuminuria define urine albumin &gt; 200 mg/day History insulin use within three month screen History diabetic ketoacidosis Treatment thiazolidinedione ( e.g. , rosiglitazone ) within three month screen History lactic acidosis metformin therapy Complications diabetes ( e.g. , neuropathy , nephropathy , retinopathy ) Clinically significant currently active disease Clinical significant abnormality medical history , physical examination , laboratory examination</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Fasting plasma glucose</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Oral antidiabetic agent ( )</keyword>
</DOC>